These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8065609)

  • 1. Increased risk of malignancy and blood-membrane interactions in uraemic patients.
    Akizawa T; Kinugasa E; Koshikawa S
    Nephrol Dial Transplant; 1994; 9 Suppl 2():162-4. PubMed ID: 8065609
    [No Abstract]   [Full Text] [Related]  

  • 2. Dialysis-related amyloidosis and acquired renal cystic disease with renal cell carcinoma in uremia.
    Wu TH; Tsai CY; Chiang SS; Wang JS; Huang TP; Yu CL
    Nephron; 1994; 67(1):129. PubMed ID: 7993425
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal cell carcinoma in dialysis patients: a single center experience.
    Kojima Y; Takahara S; Miyake O; Nonomura N; Morimoto A; Mori H
    Int J Urol; 2006 Aug; 13(8):1045-8. PubMed ID: 16903927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
    Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma in a polycystic kidney.
    Lee MH; Waxman M; Neff R
    Mt Sinai J Med; 1987 Jun; 54(5):433-5. PubMed ID: 3498894
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer and chronic renal failure.
    Digenis G; Pierratos A; Oreopoulos DG
    CMAJ; 1986 Jul; 135(1):14-6. PubMed ID: 3719478
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function.
    Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M
    Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acquired cystic renal disease. Association with hypernephroma].
    Comesaña E; Pesqueira D; Tardáguila F; De la Fuente A; Antón I; Vidal L; Zungri E
    Actas Urol Esp; 1992 Feb; 16(2):109-12. PubMed ID: 1590084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal cell carcinoma in chronic hemodialysis patients].
    Imai K; Sekino H; Terasawa Y; Nakamura K
    Nihon Rinsho; 1992 Jan; 50 Suppl():848-54. PubMed ID: 1578777
    [No Abstract]   [Full Text] [Related]  

  • 10. Interleukin/cytokine profiles in haemodialysis and in continuous peritoneal dialysis.
    Jacobs P; Glorieux G; Vanholder R
    Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V41-45. PubMed ID: 15284359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are biocompatible membranes superior for hemodialysis therapy?
    van Ypersele de Strihou C
    Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polycystic degeneration in the kidneys in dialysis patients].
    Frifelt JJ; Wienholtz G
    Ugeskr Laeger; 1988 Aug; 150(35):2064-7. PubMed ID: 3046089
    [No Abstract]   [Full Text] [Related]  

  • 13. Current trends in dialysis therapy.
    Jacobs C
    Kidney Int Suppl; 1997 Nov; 62():S93-5. PubMed ID: 9350692
    [No Abstract]   [Full Text] [Related]  

  • 14. [Amino acids supplementation therapy in uremic patients on regular blood purification treatment].
    Ando A
    Nihon Rinsho; 2004 May; 62 Suppl 5():384-8. PubMed ID: 15197950
    [No Abstract]   [Full Text] [Related]  

  • 15. Forces determining selection of uremia therapy.
    Friedman EA; Lundin AP
    Adv Nephrol Necker Hosp; 1984; 13():151-62. PubMed ID: 6433665
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews.
    MacLeod A; Grant A; Donaldson C; Khan I; Campbell M; Daly C; Lawrence P; Wallace S; Vale L; Cody J; Fitzhugh K; Montague G; Ritchie C
    Health Technol Assess; 1998; 2(5):1-166. PubMed ID: 9621129
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased incidence of malignancy in uremic patients and its significance to transplantation.
    Matos AJ; Simmons RL; Kjellstrand CM; Buselmeier TJ; Johnson TL; Najarian JS
    Transplant Proc; 1977 Mar; 9(1):1137-40. PubMed ID: 325741
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complications in the treatment of chronic uremia in polycystic kidney].
    Pèrez de Villar JH; Ocòn Pujadas JO; Mar'in Iranzo R
    Rev Clin Esp; 1974 Mar; 132(5):415-22. PubMed ID: 4831271
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation of L-arginine transport in undialysed chronic renal failure and continuous ambulatory peritoneal dialysis patients.
    Brunini TM; Roberts NB; Yaqoob MM; Ellory JC; Mann GE; Mendes Ribeiro AC
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):114-8. PubMed ID: 16445709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early uremic polyneuropathy: clinical and electromyographic study of subjects with and without treatment with extracorporeal dialysis].
    Mariani G; Cosi V; Faggi L; Zelaschi F
    Riv Neurobiol; 1971; 17(1):67-95. PubMed ID: 4333105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.